CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 219 enrolled
Drug / intervention
Difluprednate +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00430092
NCT00430092Phase 3Completed
CompareCT.gov

A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery

Sirion Therapeutics, Inc.·interventional·Posted Feb 1, 2007·Updated Jul 2, 2009

In Brief

A Phase 3 clinical trial evaluating Difluprednate and Placebo for Inflammation. Completed, enrolled 219 participants across 1 site.

Detailed Summary

The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 1, 2007
TodayJul 2, 2026
Posted 19.4 years ago

Interventions

Difluprednatedrug

Difluprednatedrug

Placebodrug